BioSpace News Archive

Business

AxoGen to Report Fourth Quarter and Full-Year 2017 Financial Results and Host Conference Call on February 28, 2018

AxoGen management will host an investment-community conference call and webcast following the release at 4:30 p.m. ET to discuss the financial results and provide a corporate update.

February 14, 2018

·

4 min read

Business

United Therapeutics Corporation to Report Fourth Quarter and Annual 2017 Financial Results Before the Market Opens on Wednesday, February 21, 2018

United Therapeutics will host a teleconference on Wednesday, February 21, 2018, at 9:00 a.m. Eastern Time.

February 14, 2018

·

1 min read

Genetown

Insulet Has Strong Presence at the International ATTD Congress; Presents Positive Study Results for Its Omnipod Horizon Hybrid Closed-Loop System

Insulet today announced promising new data for its Omnipod Horizon Automated Glucose Control System (Omnipod Horizon) hybrid closed-loop system, which will be presented at the 11th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) congress in Vienna, Austria.

February 14, 2018

·

5 min read

Business

DARPA Awards MBio Diagnostics Phase II Contract for Acute Infection Point-of-Care System

MBio Diagnostics, Inc. today announced a contract with the US Defense Advanced Research Projects Agency (DARPA) entitled, “Point-of-care Monitoring of the Host-Pathogen Interaction During Infection.”

February 14, 2018

·

2 min read

Genetown

Bioverativ Release: Haemophilia Publishes a Retrospective Analysis Investigating the Use of ELOCTATE for Immune Tolerance Induction in People with Inhibitors and Severe Hemophilia A

Bioverativ today announced the publication of a retrospective analysis investigating the use of ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] for immune tolerance induction (ITI).

February 14, 2018

·

7 min read

Business

IQVIA Reports Fourth-Quarter and Full-Year 2017 Results, Issues First-Quarter and Full-Year 2018 Guidance

Revenue for the fourth quarter of $2,161 million increased 10.7 percent on a reported basis, and 8.4 percent on a constant currency basis, compared to the fourth quarter of 2016.

February 14, 2018

·

22 min read

Business

Owens & Minor Reports 4th Quarter & Full-Year 2017 Financial Results

Owens & Minor today reported financial results for the year ended December 31, 2017, including consolidated revenues of $9.32 billion compared to the prior year’s revenues of $9.72 billion.

February 14, 2018

·

20 min read

Ferring Announces 30M CHF Investment in New Biotech Centre in Switzerland

Ferring announced today that it is expanding its capabilities in biologics through a new biotech centre which will be installed at the company’s existing headquarters and manufacturing site in Saint-Prex, Switzerland.

February 14, 2018

·

3 min read

Drug Development

Galmed Announces ARRIVE Study Data

The primary endpoint of the study was improvement of liver fat at 12 weeks, as measured by MRI-PDFF.

February 14, 2018

·

6 min read

Genetown

The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology

Bruker is pleased to announce that AOAC International has approved the MALDI Biotyper solution for two new Official Methods of Analysis for the confirmation and identification of pathogenic and non-pathogenic bacteria.

February 14, 2018

·

5 min read